Soleus Capital Management, L.P. Xeris Biopharma Holdings, Inc. Transaction History

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$1.47 - $2.36 $355,740 - $571,120
-242,000 Reduced 79.58%
62,083 $145,000
Q3 2023

Nov 14, 2023
SELL
$1.8 - $2.69 $3.15 Million - $4.71 Million
-1,750,022 Reduced 85.2%
304,083 $565,000
Q2 2023

Aug 14, 2023
BUY
$1.82 - $2.98 $3.74 Million - $6.12 Million
2,054,105 New
2,054,105 $5.38 Million

Others Institutions Holding XERS

# of Institutions
141
Shares Held
59.9M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $420M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email